Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Aderis Pharmaceuticals is a private, biopharmaceutical company engaged in small molecule drug development to treat central nervous system, cardiovascular and renal disorders. The Company currently has four product candidates in six clinical development programs. Aderis Pharmaceuticals has a strategic alliance with Schwarz Pharma AG, for the development of rotigotine CDS, a proprietary dopamine agonist formulated as a once-a-day, continuous delivery, transdermal patch. Rotigotine completed Phase III trials for Parkinson’s disease and is in Phase IIb for the treatment of Restless Legs Syndrome. The Company also has corporate collaborations with Fujisawa Healthcare, Inc. and King ( www.aderis.com )
ADERIS Pharmaceuticals Inc
85 Main Street
Hopkinton, Massachusetts 01748
USA
Tel: (508) 497-2300
Fax: (508) 497-9553